Company
United StatesPublic company, NASDAQ: BMRNBioMarin Pharmaceutical Inc. (NASDAQ: BMRN), San Rafael, CA – FDA Inspections
Inspection records and compliance data for BioMarin Pharmaceutical Inc. in San Rafael, California. 4 FDA inspections on record, last inspected November 06, 2020. Publicly traded as NASDAQ: BMRN.
Company Profile
This profile covers BioMarin Pharmaceutical Inc. based in San Rafael, California, United States.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 0
- VAI
- 2
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected February 17, 2014. Last inspected November 6, 2020.
Most cited issue areas
- Late submission of annual safety reports1 inspection
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| November 6, 2020 | NAI | Human Drugs · Bioresearch Monitoring | 1133648 |
| February 28, 2020 | VAI | Human Drugs · Bioresearch Monitoring | 1119195 |
| December 7, 2017 | NAI | Human Drugs · Bioresearch Monitoring | 1046400 |
| February 17, 2014 | VAI | Human Drugs · Bioresearch Monitoring | 867315 |
FDA documents
Other regulators (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
BioMarin Pharmaceutical Inc.
Stock ticker
BMRN
Exchange
NASDAQ
Share price
$56.70
Market cap
$11.0B
Price as of
November 13, 2026
FEI Number
3010446870
Address
770 Lindaro St, San Rafael, California 94901, United States
Country
United States
ID: 73126e34-fd3f-451a-beef-466225ecadc2